- ISIN
- GB00BYMT0J19
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Feb 10, 1993
Highlights
- Market Cap
- $3.99B
- Enterprise Value
- $3.78B
- EPS (TTM)
- $1.95
- PE Ratio
- 36.67
- PEG Ratio
- 0.74
- Total Revenue (TTM)
- $1.43B
- Gross Profit (TTM)
- $967.36M
- EBITDA (TTM)
- $206.63M
- Year Range
- $41.02 - $75.82
- Target Price
- $75.88
- ROA (TTM)
- 4.26%
- ROE (TTM)
- 8.84%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LIVN Performance Chart
LivaNova PLC (LIVN) is up 15.9% since the beginning of the year. At $71 per share, LIVN is trading 5.9% below its 52-week high of $76. Investors who bought $1,000 worth of LIVN shares 5 years ago would now be looking at an investment worth $891.
Loading charts...
Returns By Period
LivaNova PLC (LIVN) has returned 15.93% so far this year and 61.75% over the past 12 months. Over the last ten years, LIVN has returned 3.85% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
LivaNova PLC
- 1D
- -2.73%
- 1M
- 20.76%
- YTD
- 15.93%
- 6M
- 12.70%
- 1Y
- 61.75%
- 3Y*
- 15.04%
- 5Y*
- -2.29%
- 10Y*
- 3.85%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
LIVN Monthly Returns History
Based on dividend-adjusted daily data since Oct 19, 2015, LIVN's average daily return is +0.03%, while the average monthly return is +0.55%. At this rate, an investment would double in approximately 10.5 years.
Historically, 53% of months were positive and 47% were negative. The best month was Aug 2025 with a return of +33.6%, while the worst month was Mar 2020 at -35.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, LIVN closed higher 50% of trading days. The best single day was May 7, 2025 with a return of +23.7%, while the worst single day was Apr 5, 2019 at -27.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.79% | 7.44% | -9.97% | -5.44% | 22.80% | -3.35% | 15.93% | ||||||
| 2025 | 7.86% | -16.66% | -5.64% | -5.80% | 16.89% | 4.09% | -6.29% | 33.61% | -7.08% | 0.48% | 21.24% | -3.57% | 32.87% |
| 2024 | -5.91% | 12.59% | 2.06% | -0.34% | 9.54% | -10.23% | -9.89% | 2.00% | 4.27% | -1.75% | 1.70% | -11.79% | -10.49% |
| 2023 | 1.19% | -15.80% | -7.90% | 9.91% | -7.56% | 16.15% | 13.65% | -4.96% | -4.81% | -7.24% | -8.56% | 15.36% | -6.84% |
| 2022 | -14.09% | 4.94% | 3.82% | -6.32% | -11.21% | -8.23% | 1.92% | -11.65% | -9.74% | -7.23% | 17.56% | 0.31% | -36.47% |
| 2021 | -5.00% | 23.28% | -4.91% | 15.11% | -1.57% | 0.68% | 2.60% | -4.18% | -4.23% | -3.12% | 4.48% | 9.07% | 32.05% |
Benchmark Metrics
LivaNova PLC has an annualized alpha of -5.82%, beta of 1.03, and R2 of 0.21 versus S&P 500 Index. Calculated based on daily prices since October 20, 2015.
- This stock participated in 118.88% of S&P 500 Index downside but only 64.88% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.21 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -5.82%
- Beta
- 1.03
- R²
- 0.21
- Upside Capture
- 64.88%
- Downside Capture
- 118.88%
Return for Risk
Risk / Return Rank
LIVN ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for LivaNova PLC (LIVN) and compare them to S&P 500 Index.
| LIVN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.59 | ||
| Sortino ratioReturn per unit of downside risk | -0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.41 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 3.29 | 2.93 | +0.36 |
| Martin ratioReturn relative to average drawdown | 8.63 | 13.52 | -4.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the LivaNova PLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the LivaNova PLC was 74.15%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current LivaNova PLC drawdown is 45.53%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -74.15%Apr 2025 | 6y 6mo | — | 7y 8moSep 2018 - now |
2016 bear market2016 | -40.87%Nov 2016 | 1y 26d | 10mo 19d | 1y 11moOct 2015 - Sep 2017 |
2017 correction2017 | -11.03%Dec 2017 | 22d | 2mo 9d | 3mo 1dNov 2017 - Feb 2018 |
2018 pullback2018 | -8.90%May 2018 | 2mo 29d | 2d | 3mo 1dMar 2018 - May 2018 |
2018 pullback2018 | -5.27%Jun 2018 | 11d | 25d | 1mo 6dJun 2018 - Jul 2018 |
Drawdown Indicators
| LIVN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.15% | -56.78% | -17.37% |
Max Drawdown (1Y)Largest decline over 1 year | -18.89% | -9.10% | -9.79% |
Max Drawdown (3Y)Largest decline over 3 years | -47.23% | -18.90% | -28.33% |
Max Drawdown (5Y)Largest decline over 5 years | -63.48% | -25.43% | -38.05% |
Max Drawdown (10Y)Largest decline over 10 years | -74.15% | -33.92% | -40.23% |
Current DrawdownCurrent decline from peak | -45.53% | -0.74% | -44.79% |
Average DrawdownAverage peak-to-trough decline | -41.55% | -10.72% | -30.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.18% | 1.97% | +5.21% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of LivaNova PLC over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how LivaNova PLC is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for LIVN, comparing it with other companies in the Medical Devices industry. Currently, LIVN has a P/E ratio of 36.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for LIVN compared to other companies in the Medical Devices industry. LIVN currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LIVN relative to other companies in the Medical Devices industry. Currently, LIVN has a P/S ratio of 2.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for LIVN in comparison with other companies in the Medical Devices industry. Currently, LIVN has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LIVN
Add LivaNova PLC to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LIVN